Steward Partners Investment Advisory, LLC - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q3 2023$3,140
-86.7%
1,000
-78.2%
0.00%
Q2 2023$23,664
-25.2%
4,586
-23.6%
0.00%
-100.0%
Q1 2023$31,620
+22.0%
6,000
-35.0%
0.00%
Q4 2022$25,922
+8.0%
9,225
+61.1%
0.00%
Q3 2022$24,000
+242.9%
5,725
+231.9%
0.00%
Q2 2022$7,000
-22.2%
1,7250.0%0.00%
Q1 2022$9,000
-25.0%
1,7250.0%0.00%
Q4 2021$12,000
-29.4%
1,7250.0%0.00%
Q3 2021$17,000
-29.2%
1,7250.0%0.00%
Q2 2021$24,000
-100.0%
1,725
-50.0%
0.00%
Q1 2021$56,614,000
+157161.1%
3,450
+100.0%
0.00%
-100.0%
Q4 2020$36,000
+260.0%
1,725
+25.5%
0.00%
Q3 2020$10,000
+25.0%
1,375
+37.5%
0.00%
Q2 2020$8,000
+100.0%
1,0000.0%0.00%
Q1 2020$4,000
+33.3%
1,0000.0%0.00%
Q4 2019$3,0000.0%1,0000.0%0.00%
Q3 2019$3,000
-25.0%
1,0000.0%0.00%
Q2 2019$4,0001,0000.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2020
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders